| 216178 |
FRONTIERS IN MICROBIOLOGY |
Heroin inhibits HIV-restriction miRNAs and enhances HIV infection of macrophages |
2015-11-04 |
10.3389/fmicb.2015.01230 |
Wang Xu, Ma Tong-Cui, Li Jie-Liang, Zhou Yu, Geller Ellen B., Adler Martin W., Peng Jin-Song, Zhou Wang, Zhou Dun-Jin, Ho Wen-Zhe |
| 216177 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Induction of potent systemic anti-melanoma immunity through intratumoral CD40 activation and checkpoint blockade |
2015-11-04 |
10.1186/2051-1426-3-s2-p313 |
Singh Manisha, Dai Zhimin, Khong Hiep, Vianden Christina, Cantwell Mark, Overwijk Willem |
| 216176 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Randomized Phase II study of the safety, efficacy and immune response of GVAX pancreas (with cyclophosphamide) and CRS-207 with or without nivolumab in patients with previously treated metastatic pancreatic adenocarcinoma (STELLAR) |
2015-11-04 |
10.1186/2051-1426-3-s2-p155 |
Le Dung T, Crocenzi Todd S, Urum Jennifer N, Lutz Eric R, Laheru Daniel A, Sugar Elizabeth A, Vonderheide Robert H, Fisher George A, Ko Andrew H, Murphy Aimee L, McDougall Katherine, Ferber Sandy, Brockstedt Dirk G, Jaffee Elizabeth M |
| 216175 |
FRONTIERS IN MICROBIOLOGY |
Self-healing of early age cracks in cement-based materials by mineralization of carbonic anhydrase microorganism |
2015-11-04 |
10.3389/fmicb.2015.01225 |
Qian Chunxiang, Chen Huaicheng, Ren Lifu, Luo Mian |
| 216174 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Cytomegalovirus-specific CD8 T cells kill B16 melanoma cells in vivo when activated by bifunctional major histocompatibility class I - antibody fusion molecules (pMHCI-IgGs). |
2015-11-04 |
10.1186/2051-1426-3-s2-p237 |
Munks Michael, Levitsky Victor, Hill Ann, Knoetgen Hendrik |
| 216173 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Development and optimization of PSCA-specific CAR T cells for the treatment of bone metastatic prostate cancer |
2015-11-04 |
10.1186/2051-1426-3-s2-p115 |
Gerdts Ethan, Priceman Saul, Tilakawardane Dileshni, Park Anthony, Chang Wen-Chung, Wright Sarah, Brown Christine E, Forman Stephen J |
| 216172 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Computational discovery and experimental validation of novel drug targets in immuno-oncology |
2015-11-04 |
10.1186/2051-1426-3-s2-p184 |
Levy Ofer, Machelnkin Arthur, Rotman Galit, Toporik Amir, Cojocaro Gady, Dassa Liat, Vaknin Ilan, Liang Spencer, Hunter John, Neria Eyal, Levin Zurit |
| 216171 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Adoptive immunotherapy for AML with CD123-engager T cells |
2015-11-04 |
10.1186/2051-1426-3-s2-p3 |
Bonifant Challice, Torres David, Joseph Nicholos, Barth Carolyn Arber, Velasquez Mireya, Song Xiao-Tong, Redell Michele, Gottschalk Stephen |
| 216170 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
FAP-specific re-directed T cells first in-man study in malignant pleural mesothelioma: experience of the first patient treated |
2015-11-04 |
10.1186/2051-1426-3-s2-p120 |
Pircher Magdalena, Schuberth Petra, Gulati Pratiksha, Sulser Simon, Weder Walter, Curioni Alessandra, Renner Christoph, Petrausch Ulf |
| 216169 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Cytokines and TLR agonists influence the expression of retention integrins CD49a, CD49b and CD103 by T cells |
2015-11-04 |
10.1186/2051-1426-3-s2-p235 |
Melssen Marit M, Hutchison Ciara, Mauldin Ileana S, Bullock Timothy N, Slingluff Craig L |
